Canopy Growth (CGC) Current Taxes (2021)

Canopy Growth (CGC) reported Current Taxes of $6.1 million for Q4 2021, up 15.15% sequentially from $5.3 million in Q3 2021.

Canopy Growth (CGC) Current Taxes (2021) Analysis & Trends

Canopy Growth (CGC) has 1 years of Current Taxes data on file, last reported at $6.1 million in Q4 2021.

For the quarter ending Q4 2021, Current Taxes changed N/A year-over-year to $6.1 million; the trailing twelve-month figure through Dec 2021 stood at $6.1 million (changed N/A YoY), and the FY2021 full-year result was $10.7 million, changed N/A from the prior year.
Current Taxes improved to $6.1 million in Q4 2021, from $5.3 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $11.6 million in Q2 2021 to a low of $5.3 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	355.15 Mn
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	211.00 Mn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	624.14 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	640.78 Mn
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Canopy Growth	197.77 Mn	-68.15 Mn	-	-

Download Data